Arrowhead Pharmaceuticals (ARWR) Total Debt Growth (5y) (2016 - 2024)
Arrowhead Pharmaceuticals (ARWR) Total Debt Growth (5y) (2016 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Arrowhead Pharmaceuticals | 11.98 Bn | 10.18 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 170.80% |
| Sep 30, 2018 | 111.20% |
| Jun 30, 2018 | 112.35% |
| Mar 31, 2018 | 113.44% |
| Dec 31, 2017 | 114.50% |
| Sep 30, 2017 | 22.60% |
| Jun 30, 2017 | 24.55% |
| Mar 31, 2017 | 26.58% |
| Dec 31, 2016 | 28.72% |
| Sep 30, 2016 | 33.09% |
| Jun 30, 2016 | 35.73% |